InterGlobal has enhanced the cover for cancer treatment available through its 2014 UltraCare international private medical insurance (IPMI) scheme.
The international medical insurer has removed previous benefit limits and excesses for cancer from its plan.
Its UltraCare Standard, Select, Comprehensive and Elite plans will now cover the costs of all in-patient, day care, out-patient and palliative care, which will be paid in full up to overall plan limits of between US$1.5 million (£900,000) and US$5 million (£3.1 million).
It has also increased its overall plan limits, more than doubling the maximum it will pay through its UltraCare Comprehensive plan to US$4 million (£2.4 million), and increasing all plan limits by between nearly 50% and 135%.
Stephen Hartigan (pictured), chief executive of InterGlobal, said: “With the survivability of cancer improving all the time, we want to make sure that our UltraCare members receive top-quality cancer treatment anywhere in the world, knowing that we are committed to picking up the bill in full, with no ifs and buts.”
Paul Weigall, group sales and marketing director at InterGlobal, added: “As well as improvements to cancer care cover and out-patient benefits, we have also increased plan limits across the board to ensure our UltraCare plans more than meet the needs of our international members wherever they are in the world.
“We realise that the cost of international health insurance is a concern for many employers and we are committed to holding premium increases on our plans to well below the level of medical cost inflation.”
